Newcastle disease virus activated human peripheral blood mononuclear cells and their use in cancer therapy.
This invention provides a method for immune activation of human peripheral blood mononuclear cells (PBMC) by treatment with immunogens derived from New Castle Disease virus (NDV). The invention describes a method of activation of PBMC by NDV, the activated PBMCs produced by the inventive method as w...
Main Authors: | Mohammed Alitheen, Noorjahan Banu, Lam, Han Yuen, Yusoff, Khatijah, Abd Aziz, Suraini, Keong, Yeap Swee |
---|---|
Format: | Patent |
Published: |
2010
|
Similar Items
-
Immunomodulatory effects of Newcastle disease virus AF2240 strain on human peripheral blood mononuclear cells
by: Lam, Han Yuen, et al.
Published: (2014) -
Safety and clinical usage of Newcastle disease virus in cancer therapy.
by: Lam, Han Yuen, et al.
Published: (2011) -
Immunomodulatory Effects of Newcastle Disease Virus Strain AF2240 on Human Peripheral Blood Mononuclear Cells Activation and Cytolytic Activity
by: Lam, Han Yuen
Published: (2011) -
Immunomodulatory role of Rhaphidophora korthalsii methanol extract on human peripheral blood mononuclear cell proliferation, cytokine secretion and cytolytic activity.
by: Yeap, Swee Keong, et al.
Published: (2011) -
Responses of enriched chicken b lymphocytes population towards infection of different genotypes of velogenic Newcastle disease virus
by: Teo, Kristeen Ye Wen, et al.
Published: (2013)